MustGrow Biologics 

C$1.49
13
+C$0.03+2.05% 今天

統計

當日最高
-
當日最低
-
52週最高
-
52週最低
-
成交量
-
平均成交量
-
市值
76.94M
市盈率
0
股息收益率
-
股息
-

即將到來

收益

27Nov預期
Q1 2022
Q2 2022
Q3 2022
Q3 2023
Q1 2024
Q2 2024
下一個
-0.04
-0.03
-0.02
-0.01
預期每股收益
-0.04079615124
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 MGRO.V 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, it is developing TerraSante, an organic soil amendment and biofertility technology. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.
Show more...
首席執行官
Mr. Corey J. Giasson B.Sc., MBA
國家
CA
ISIN
CA62822A1030

上市公司